Daehan Nupharm Co.,Ltd. (KOSDAQ:054670)
5,190.00
+20.00 (0.39%)
At close: Oct 23, 2026
Daehan Nupharm Market Cap
Daehan Nupharm has a market cap or net worth of 72.84 billion as of October 23, 2026. It is the 29,398th most valuable company in the world and the 1,498th biggest in South Korea. Its market cap has decreased by 22.07% in one year.
Market Cap
72.84B
Enterprise Value
136.18B
Revenue
211.48B
Global Rank
Country Rank
#1,498 South Korea
PE Ratio
3.04
ChartMarket Cap Chart
Since March 3, 2003, Daehan Nupharm's market cap has increased from 13.03B to 72.84B, an increase of 458.96%. That is a compound annual growth rate of 7.55%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 72.84B | -21.00% |
| Dec 30, 2025 | 92.21B | -4.37% |
| Dec 30, 2024 | 96.42B | -24.09% |
| Dec 28, 2023 | 127.02B | 5.97% |
| Dec 29, 2022 | 119.86B | -21.65% |
| Dec 30, 2021 | 152.98B | -13.49% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| KOREA PHARMA | 91.40B |
| WITHUS PHARMACEUTICAL Co.,LTD. | 90.55B |
| Samik Pharmaceutical Company LTD. | 84.17B |
| H.PIO | 83.64B |
| Sam-A Pharm. | 83.31B |
| Pharos iBio | 80.78B |
| Polaris AI Pharma | 75.98B |
| Sinil Pharmaceutical | 72.35B |